Case Summary:               

Behind every major public health milestone lies a fusion of expertise, precision, and innovation. For a clinical assistant professor focused on interventional neuroradiology, this combination is not theoretical—it is the foundation of a medical journey aimed at reducing the economic and human burden of stroke-related disabilities. With the approval of his EB-2 NIW (National Interest Waiver) petition, his efforts have now been formally recognized as beneficial to the United States.

Treating Stroke with Innovation, Not Just Intervention

The client’s proposed endeavor focuses on improving acute ischemic stroke treatment through advancements in mechanical thrombectomy procedures and the development of next-generation neurointerventional devices. His goal is ambitious yet clear: reduce stroke-induced disabilities and associated healthcare costs by optimizing the safety, precision, and efficacy of endovascular procedures.

An Accomplished Record of Scholarship

With 34 peer-reviewed journal articles, 7 first-authored abstracts, and 1 patent, cited 130 times, the client has an established publication and citation record that reflects depth and consistency.

National Importance, Demonstrated Influence

What sets this case apart is not just the volume of work but its application across national and global health systems. The key highlights of his work include:

• His findings on post-stroke depression influenced mental health treatment models.
• His thrombectomy timing analysis informed guidelines on late-window interventions.
• His work on Doppler screening helped validate less invasive diagnostic tools.

These citations are not perfunctory—they are foundational. They demonstrate how his results are used to guide both clinical decision-making and further innovation in stroke care.

Approved with RFE: A Case of Convincing Merit

Despite a Request for Evidence (RFE) issued in late 2024, NAILG successfully responded with a comprehensive case file highlighting:

• Extensive evidence of field impact (via percentile-ranked citations),
• Documented speaking engagements and peer recognition,
• Tangible alignment with U.S. healthcare priorities, and
• Independent confirmation of national importance from leading experts.

The petition was approved less than four months after filing, reflecting both the strength of the evidence and the efficiency of the presentation.

Conclusion

With EB-2 NIW approval now secured, this physician-scientist stands poised to further develop transformative stroke interventions that serve both patient outcomes and national healthcare sustainability. At NAILG, we are proud to have supported this critical milestone and look forward to seeing the continuing influence of his work on health systems and lives across the United States.